Welch Investments’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$6.01M Sell
62,165
-3,439
-5% -$324K 3.82% 1
2017
Q3
$5.83M Sell
65,604
-433
-0.7% -$33K 4.02% 1
2017
Q2
$4.79M Buy
66,037
+2,939
+5% +$198K 3.56% 3
2017
Q1
$4.11M Buy
63,098
+4,151
+7% +$261K 3.26% 13
2016
Q4
$3.69M Buy
+58,947
New +$3.6M 3.23% 15

Other funds holding ABBV

Welch Investments's ABBV Position: Q4 2017 in Review

Welch Investments reduced its AbbVie (ABBV) stake by 5.2% in Q4 2017, selling an estimated $324K and leaving 62,165 shares worth $6.01M. The position accounts for 3.82% of the portfolio, ranked #1.

Welch Investments first reported a position in ABBV in Q4 2016 and has held it in 5 quarters since. 2,000 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

  • Welch Investments held 62,165 shares of AbbVie worth $6.01M as of Q4 2017.
  • Welch Investments sold 3,439 AbbVie shares in Q4 2017, an estimated $324K.
  • AbbVie made up 3.82% of Welch Investments's portfolio in Q4 2017, its #1 holding.
  • Welch Investments first reported a position in AbbVie in Q4 2016 and has held it in 5 quarters since.
  • 2,000 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on Welch Investments's 13F filing for Q4 2017, filed 30 Jan 2018.